Electrophysiology
Cobalt™ and Crome™ ICD and CRT-D portfolio
Learn about transvenous implantable cardioverter defibrillators (ICDs) used for tachyarrhythmia management.
The Cobalt™ and Crome™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy - defibrillator (CRT-D) portfolio is enabled with 40 J energy availability on the first shock and every shock,1 extended longevity, and BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring to streamline the patient and provider experience.1 Select models include intrinsic antitachycardia pacing (iATP) which is the only automated and smart antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time,2 exclusive algorithms to manage atrial fibrillation (AF), and compatibility with a simplified heart failure risk stratification tool to help meet the needs of physicians and their patients.
Watch our journey.
Watch the video to learn how our new ICD and CRT-D portfolio is delivering innovation to help meet the needs of patients and physicians.